These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1053884)
1. Hemophilia: acquired modifications of the genetic disorder. Hampton JW; Warner D Ann N Y Acad Sci; 1975 Jan; 240():405-6. PubMed ID: 1053884 [No Abstract] [Full Text] [Related]
2. Use of animal AHG concentrates (factor VIII) in the treatment of life-threatening hemorrhage in patients with factor VIII antibodies. Rubin R; Niemetz J; Estren S Ann N Y Acad Sci; 1975 Jan; 240():362-9. PubMed ID: 1053881 [No Abstract] [Full Text] [Related]
3. Successful management of a subdural hematoma in a hemophiliac with an anti-factor VIII antibody. Edson JR; McArthur JR; Branda RF; McCullough JJ; Chou SN Blood; 1973 Jan; 41(1):113-22. PubMed ID: 4682073 [No Abstract] [Full Text] [Related]
4. The suppression of factor VIII antibodies in haemophilia. Dormandy KM; Sultan Y Pathol Biol (Paris); 1975 Dec; 23 suppl():17-23. PubMed ID: 772555 [TBL] [Abstract][Full Text] [Related]
5. Failure of combined factor VIII and cyclophosphamide to suppress antibody to factor VIII in hemophilia. Hruby MA; Schulman I Blood; 1973 Dec; 42(6):919-23. PubMed ID: 4759918 [No Abstract] [Full Text] [Related]
6. Preliminary trial of cyclophosphamide in the management of hemophiliacs with factor VIII inhibitors. Ruggeri ZM; Mannucci PM; Allain JP; Frommel D Ann N Y Acad Sci; 1975 Jan; 240():412-8. PubMed ID: 1053886 [No Abstract] [Full Text] [Related]
7. Characterization of factor VIII antibodies. Shapiro SS Ann N Y Acad Sci; 1975 Jan; 240():350-61. PubMed ID: 46139 [No Abstract] [Full Text] [Related]
11. Letter: Hemophilia: cyclophosphamide and factor VIII concentrate. Stein RS Ann Intern Med; 1974 Nov; 81(5):706-7. PubMed ID: 4419955 [No Abstract] [Full Text] [Related]
12. Development of factor VIII antibody in haemophilic monozygotic twins. European Study Group of Factor VIII Antibody. Scand J Haematol; 1979 Jul; 23(1):64-8. PubMed ID: 573920 [TBL] [Abstract][Full Text] [Related]
13. [Inhibitors (antibodies) directed against factor VIII in hemophilia A (author's transl)]. Beck EA Ther Umsch; 1979 Apr; 36(4):326-9. PubMed ID: 377556 [No Abstract] [Full Text] [Related]
14. [Studies on the usefulness of double filtration plasmapheresis in a hemophilia A patient with anti-factor VIII antibody (inhibitor)]. Okubo S; Ikuma T; Hamaguchi Y; Yasunaga K Rinsho Ketsueki; 1985 May; 26(5):701-8. PubMed ID: 3932716 [No Abstract] [Full Text] [Related]
15. Idiopathic inhibitor of factor VIII and its treatment by immunosuppression. Ting HC; Wang F; Por P; Nurulhuda A Acta Haematol; 1980; 64(4):236-8. PubMed ID: 6781207 [TBL] [Abstract][Full Text] [Related]
17. Saving of cryoprecipitate in the surgery of hemophilic patients. Storti E; Ascari E; Molinari E; Gamba G N Engl J Med; 1972 Jul; 287(4):198-9. PubMed ID: 5033536 [No Abstract] [Full Text] [Related]
18. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide. Nilsson IM; Hedner U; Holmberg L Acta Med Scand; 1974; 195(1-2):64-72. PubMed ID: 4817094 [No Abstract] [Full Text] [Related]
19. Immunosuppression of patients with acquired factor VIII inhibitors. Green D Semin Hematol; 1994 Apr; 31(2 Suppl 4):60-1. PubMed ID: 7939780 [No Abstract] [Full Text] [Related]
20. Molecular immunology of factor VIII. Zimmerman TS; Edgington TS Annu Rev Med; 1974; 25():303-14. PubMed ID: 4132887 [No Abstract] [Full Text] [Related] [Next] [New Search]